Please login to the form below

Not currently logged in
Email:
Password:

ReNeuron makes shifts and additions to senior team

Including Sharon Grimster being named as general manager for Wales

edit-Sharon-GrimsterUK-based stem cell therapy company ReNeuron has announced a number of board and senior management changes.

Sharon Grimster has been named as general manager for Wales. Grimster has worked at the firm as interim chief development officer since last year and will now take on further responsibility for the development of ReNeuron's in-house manufacturing capability when it relocates its operations to South Wales later this year.

Grimster has extensive experience in advanced biologics development as has served in senior developments roles at businesses including F-star, Antisoma and Celltech.

Dr Randolph Corteling has been promoted to head of research from his current role of head of cell biology after joining in 2007. 

Olav Hellebø, CEO of ReNeuron, commented: “I am delighted to welcome Sharon Grimster and Randolph Corteling to the senior management team at ReNeuron.  Their skills and experience will be invaluable as ReNeuron continues its transition into a fully fledged clinical development business.”

Additionally, John Berriman, a non-executive director since 2011, has taken on the role of chairman after Bryan Morton stepped down.

Mark Docherty, a non-executive director since 2005, with step down from the role in September while John Sinden, chief scientific officer (CSO) and co-founder of ReNeuron and a board member since the beginning, will also step down from the board. Sinden will continue in his role as CSO.

Concerning the board alteration, Hellebø added: “I would also like to thank Bryan Morton and Mark Docherty for the immense contribution they have both made to the company's success over their respective long tenures on the board and to welcome John Berriman to the role of chairman.”

2nd April 2015

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics